“I see these terms "stark"..."robust"..."Substantial"...WTF...do any of these mean in terms of numbers...percentages...compared to normalized baseline.”

Yeah, that’s kinda what I was thinking too. I was hoping somebody data would post some data from their studies.

I’ll see if I can google some more facts. But to me, it seems like Gilead saw some benefit primary biliary cholangitis (PBC) and then a paper came out showing stark fibrosis reduction in mice.